Aristea Therapeutics Email Format

BiotechnologyCalifornia, United States11-50 Employees

Aristea Therapeutics is a clinical-stage biotechnology company focused on developing therapies for serious inflammatory diseases. Based in San Diego, California, the organization leverages its drug-development experience to advance a pipeline of novel therapeutics and pursue synergistic partnerships. Its lead program, RIST4721, is in Phase 2 development and is being evaluated for palmoplantar pustulosis and other neutrophil-mediated inflammatory conditions. The company operates within the biotechnology research sector, with an emphasis on immunology-driven drug development.

Its target patient population includes individuals affected by rare inflammatory diseases, notably palmoplantar pustulosis. Aristea has a collaboration with Arena Pharmaceuticals to advance RIST4721 for PPP and other neutrophil-mediated diseases. The company focuses on forming partnerships to accelerate clinical development and broaden its pipeline.

Get verified Aristea Therapeutics emails free

Company overview Employee directory